Giá của Neovacs S.A. là bao nhiêu (ALNEV)

Giá của Neovacs S.A. (ALNEV) là $0.00047446

Mũ thị trường của Neovacs S.A. là gì (ALNEV)

Giới hạn thị trường của Neovacs S.A. (ALNEV) là $82.80

Thu nhập Neovacs S.A. (ALNEV)

Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.

Năm	Thu nhập	Thay đổi
2026 (TTM)	$-35.33M	0.00%
2024	$-35.33M	232.17%
2023	$-10.63M	128.13%
2022	$-4.66M	-67.15%
2021	$-14.19M	74.31%
2020	$-8.14M	-22.00%
2019	$-10.44M	-33.00%
2018	$-15.58M	-31.17%
2017	$-22.63M	24.13%
2016	$-18.23M	131.65%
2015	$-7.87M	-33.75%
2014	$-11.88M	7.75%
2013	$-11.03M	0.62%
2012	$-10.96M	-12.83%
2011	$-12.57M	-8.71%
2010	$-13.77M	14.01%
2009	$-12.08M	72.06%
2008	$-7.02M	-9.80%
2007	$-7.78M	0.00%

Năm

Thu nhập

Thay đổi

2026 (TTM)

$-35.33M

0.00%

2024

$-35.33M

232.17%

2023

$-10.63M

128.13%

2022

$-4.66M

-67.15%

2021

$-14.19M

74.31%

2020

$-8.14M

-22.00%

2019

$-10.44M

-33.00%

2018

$-15.58M

-31.17%

2017

$-22.63M

24.13%

2016

$-18.23M

131.65%

2015

$-7.87M

-33.75%

2014

$-11.88M

7.75%

2013

$-11.03M

0.62%

2012

$-10.96M

-12.83%

2011

$-12.57M

-8.71%

2010

$-13.77M

14.01%

2009

$-12.08M

72.06%

2008

$-7.02M

-9.80%

2007

$-7.78M

0.00%

Công ty	Thu nhập	Chênh lệch thu nhập	Quốc gia
Novo Nordisk A/S NVO.US	$20.51B	-58,146.44%	DK
Vertex Pharmaceuticals Incorporated VRTX.US	$4.64B	-13,244.00%	US
Regeneron Pharmaceuticals, Inc. REGN.US	$5.23B	-14,907.10%	US
UCB SA UCB.BR	$2.14B	-6,151.40%	BE
Argenx SE ARGX.US	$1.45B	-4,207.73%	NL

Công ty

Thu nhập

Chênh lệch thu nhập

Quốc gia